Display Settings:

Format

Send to:

Choose Destination
    Kidney Int. 2006 Oct;70(7):1198-200.

    Treatment of the primary hyperoxalurias: a new chapter.

    Source

    Mayo Clinic Hyperoxaluria Center, Rochester, Minnesota 55905, USA. milliner.dawn@mayo.edu

    Abstract

    Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.

    PMID:
    16988727
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk